Severe Congenital Neutropenia Type 4 (SCN4)

Severe congenital neutropenia type 4 is a rare, inherited immune disorder. Babies are born with very low numbers of neutrophils, which are white blood cells that fight germs. The shortage is present from birth and causes frequent, serious infections early in life. SCN4 happens when a child inherits two faulty copies of a gene called G6PC3. This gene helps neutrophils keep their energy balance inside the cell. When it does not work, the cells get stressed and die too early, and they also work poorly. Because neutrophils are few and weak, infections keep coming back. Some children with SCN4 also have heart problems, a visible pattern of veins on the skin, liver or spleen enlargement, and sometimes lung blood pressure problems. SCN4 is autosomal recessive, which means both parents usually carry one silent faulty copy and have healthy blood counts themselves. Wikipedia+4PMC+4BioMed Central+4

SCN4 is a rare, inherited condition. A baby is born with very low neutrophils (the white blood cells that fight bacteria). The cause is harmful changes in the G6PC3 gene. Because neutrophils are missing or very low, infections start early in life and can be severe. Some people also have other body findings (for example, heart, vein, or urogenital differences). The bone marrow shows a “maturation stop”—cells do not fully grow into neutrophils. With the right care (infection prevention, prompt antibiotics, and medicines that raise neutrophils), life can be safer. In a few cases that do not respond, a stem-cell transplant can cure the marrow problem. ASH Publications+3PMC+3orpha.net+3

Other names

Doctors may also write: “G6PC3 deficiency,” “Severe congenital neutropenia due to G6PC3 mutation,” “Autosomal recessive SCN4,” or “Dursun syndrome” (a syndromic form with lung-artery hypertension reported in some patients). These terms describe the same condition or closely related presentations caused by changes in the G6PC3 gene. ScienceDirect+1

Types

There is one core disease—neutropenia from G6PC3 mutations—but the presentation varies:

1. Syndromic SCN4: Neutropenia plus other features such as visible superficial veins that can later become varicose veins or ulcers, congenital heart defects (like secundum atrial septal defect or patent ductus arteriosus), intermittent low platelets, and in some families severe lung-artery hypertension. Nature+1

2. Non-syndromic SCN4: Mainly neutropenia and infections, with few or no structural anomalies. Both forms arise from G6PC3 variants; the difference is the extra findings. ScienceDirect

Causes

Remember: all cases are rooted in biallelic G6PC3 variants. Below are 20 concrete, easy-to-grasp “causes” or drivers inside that single genetic cause—some are gene-level reasons, others are cell-level effects that actually cause the neutropenia and infections.

1. Two faulty G6PC3 copies inherited (autosomal recessive). This is the primary cause. PMC+1

2. Missense or truncating mutations in G6PC3 that reduce or abolish enzyme function. ScienceDirect

3. Loss of glucose-6-phosphatase-β activity inside the endoplasmic reticulum of neutrophils. Frontiers

4. Energy imbalance in neutrophils, because they cannot properly convert glucose-6-phosphate to glucose in the ER lumen. Frontiers

5. Endoplasmic-reticulum (ER) stress triggered by that energy problem. Frontiers

6. Increased neutrophil apoptosis (early cell death) from stress signals. Frontiers

7. Poor respiratory burst (weak production of germ-killing reactive oxygen species). Frontiers

8. Reduced chemotaxis (neutrophils move slowly or poorly to infection sites). Frontiers

9. Abnormal calcium mobilization in neutrophils. Frontiers

10. Impaired phagocytosis (weaker engulfing of bacteria and fungi). Frontiers

11. Bone-marrow maturation arrest of neutrophil precursors (cells stall before becoming fully mature). PMC

12. Intermittent low platelets in some patients, adding bleeding risk and complicating infections. Wikipedia

13. Congenital heart defects that worsen illness severity and recovery from infections. Nature

14. Abnormal superficial veins that can progress to varicosities and ulcers, increasing skin-infection risk. Nature

15. Pulmonary hypertension reported in a subset (makes chest infections more dangerous). Wikipedia

16. Hepatosplenomegaly (enlarged liver/spleen) reflecting systemic stress and recurrent infections. orpha.net

17. Large platelets in some cases, an unusual lab feature that may point to SCN4. PubMed

18. Consanguinity / shared ancestry increases the chance both parents carry the same rare G6PC3 variant. (General autosomal-recessive genetics principle in reported cohorts.) PMC

19. Founder variants within specific populations or families (reported in SCN cohorts). PMC

20. Diagnostic delay (not a genetic cause, but it prolongs neutropenia-driven damage because treatment is late). Clinicians stress testing G6PC3 in any infant with unexplained congenital neutropenia. PubMed

Symptoms

Children often show many of these:

1. Frequent infections starting in the first months of life. MedlinePlus

2. Fevers that keep returning, often with no clear source at first. MedlinePlus

3. Skin infections (boils, abscesses) and cellulitis. MedlinePlus

4. Mouth ulcers and gum disease (gingivitis, periodontitis). MedlinePlus

5. Ear, nose, and throat infections (otitis, sinusitis, pharyngitis). MedlinePlus

6. Pneumonia and other chest infections. MedlinePlus

7. Liver abscesses or other deep infections in severe cases. MedlinePlus

8. Poor weight gain during bad infection periods. orpha.net

9. Enlarged liver or spleen on exam. orpha.net

10. Visible surface veins that can become varicose with age. Nature

11. Easy bruising or bleeding when platelets are low. Wikipedia

12. Shortness of breath if pulmonary hypertension is present. Wikipedia

13. Fatigue out of proportion to minor illnesses. orpha.net

14. Recurrent mouth thrush or fungal infections, due to weak neutrophil function. orpha.net

15. Complications from hospital stays (IV line infections, slow healing). orpha.net

Diagnostic tests

A) Physical examination 

1. General check with fever charting and growth review. Doctors document fevers, weight, and height over time, because early, repeated infections and poor growth point to congenital neutropenia. MedlinePlus

2. Skin and soft-tissue exam. They look for boils, abscesses, and varicose or ulcerated superficial veins that can appear in SCN4. Nature

3. Mouth and gum exam. Recurrent mouth ulcers, swollen gums, or tooth loss suggest chronic neutropenia. MedlinePlus

4. Heart and lung exam. Murmurs can suggest congenital heart defects; breathing signs can suggest pneumonia or, rarely, pulmonary hypertension. Nature+1

5. Abdomen exam for liver/spleen size. Hepatosplenomegaly is common in syndromic cases and after many infections. orpha.net

B) Manual / bedside clinical tests 

6. Serial temperature logs at home. Repeated fevers signal breakthrough infections in neutropenia. MedlinePlus

7. Oral swab and wound swab collection. Simple swabs guide antibiotic choice and document recurrent bacterial infections. orpha.net

8. Handheld pulse oximetry. Quick oxygen checks are useful if lung disease or pulmonary hypertension is suspected. Wikipedia

9. Capillary refill and perfusion checks. These bedside checks help assess circulatory impact during sepsis episodes. (Supportive practice in infection care.) orpha.net

10. Growth-chart plotting. Persistent dips during infection clusters can support the suspicion of chronic neutropenia. MedlinePlus

C) Laboratory and pathological tests 

11. Complete blood count (CBC) with differential, repeated. Shows a very low absolute neutrophil count (ANC). Repeating the test proves it is persistent, not a one-time dip. MedlinePlus

12. Bone-marrow aspiration/biopsy. Often shows “maturation arrest” where neutrophil precursors stall and fail to mature. PMC

13. Genetic testing for G6PC3 variants. Next-generation panels for congenital neutropenia look for changes in >30 genes, including G6PC3; a clear biallelic pathogenic variant confirms SCN4. Mayo Clinic Laboratories

14. Neutrophil function testing (e.g., oxidative burst by DHR assay). SCN4 can show reduced respiratory burst. Frontiers

15. Apoptosis / ER-stress markers in research settings. Studies show increased apoptosis and ER stress in G6PC3-deficient neutrophils; not routine, but explains the biology. Frontiers

16. Basic metabolic panel and liver tests. These help manage complications of infections and monitor for organ involvement. orpha.net

17. Immunoglobulin levels and vaccine antibody titers (context-dependent). Useful for excluding additional immune defects when infections are severe. PMC

D) Electrodiagnostic / monitoring tests 

18. Electrocardiogram (ECG). Screens rhythm and chamber strain when congenital heart disease or pulmonary hypertension is suspected. Nature+1

19. Ambulatory pulse-ox or overnight oximetry. Helps detect silent hypoxemia in children with suspected lung vascular disease. Wikipedia

20. Blood-pressure and perfusion monitoring during infections. Supports sepsis care in children with severe neutropenia. (Standard infection care principles.) orpha.net

E) Imaging tests (additional key tools often used along the way)

• Chest X-ray or chest CT to find pneumonia or deep infections.

• Echocardiogram to look for septal defects, ductus arteriosus, valve disease, or pulmonary hypertension when suspected from exam.

• Abdominal ultrasound to check liver and spleen size and to look for abscesses.

• Venous Doppler ultrasound to assess varicose veins or leg ulcers in older individuals with SCN4. Nature+2Wikipedia+2

Non-pharmacological treatments (therapies & others)

1. Fast medical attention for fever (≥38 °C once or ≥38.3 °C once).
   Fever in severe neutropenia can mean a serious infection. Family and caregivers should treat fever as an emergency and go to care at once. Early assessment and quick antibiotics lower risk of sepsis. Infectious Diseases Society of America+1

2. Home infection-prevention plan (hand hygiene).
   Frequent handwashing with soap and water or alcohol rub reduces germs that cause infections. Everyone who touches the child should clean hands the right way and at key moments (before meals, after toilet, after changing dressings). This simple step cuts infection spread. World Health Organization+1

3. Wound and skin care routine.
   Clean small cuts quickly, keep nails short, avoid picking skin, and treat rashes. Good skin care lowers the chance that skin bacteria enter the body. Daily inspection helps catch problems early. MedlinePlus

4. Mouth care (daily brushing, soft brush, antiseptic rinses if advised).
   Mouth ulcers and gum swelling are common in congenital neutropenia. Gentle but regular oral care reduces mouth bacteria and pain and lowers infection risk that can spread. Dental visits should be frequent. NCBI

5. Food safety at home.
   Use safe water, wash produce, cook meat well, avoid unpasteurized milk and undercooked eggs. Safe food handling reduces gut infections in neutropenia. OUP Academic

6. Avoid unnecessary invasive devices.
   Limit use of catheters or lines when possible. Each device is a path for germs. Removing unneeded lines lowers bloodstream infection risk. OUP Academic

7. Vaccination plan with clinicians.
   Inactivated vaccines are recommended on schedule (e.g., flu, pneumococcal). Live vaccines may be considered depending on overall immune status; decisions should follow expert guidance. A vaccine plan reduces preventable infections. CDC+2CDC+2

8. School/day-care infection control.
   Teach hand hygiene, keep distance from sick contacts, and follow policies on illness at school. This lowers exposure to respiratory and stomach bugs. World Health Organization

9. Early dental referral.
   Regular professional cleaning and early treatment of cavities reduce mouth infections and bacteremia risk. Dentists can guide safe care when counts are low. NCBI

10. Household flu prevention.
    Annual influenza shots for close contacts and staying home when ill reduce exposure for the child with neutropenia. CDC

11. Environmental hygiene.
    Keep living spaces clean, manage trash, and handle pet waste safely. Routine cleaning lowers germ load without over-sterilizing the home. World Health Organization

12. Sun-/skin protection for fragile skin.
    Moisturizers and gentle soaps protect the skin barrier, which is the first defense against bacteria. Preventing cracks reduces entry points for germs. CDC

13. Travel readiness plan.
    Carry a summary letter, thermometer, and clear “go-to ER” instructions for fever. This speeds care if illness happens away from home. Infectious Diseases Society of America

14. Nutrition for growth and healing.
    Balanced meals with adequate protein, vitamins, and minerals support tissue repair and immune function. Diet cannot “cure” SCN4 but supports recovery. MedlinePlus

15. Household smoking avoidance.
    Second-hand smoke harms airway defenses and increases infections. A smoke-free home lowers risk. OUP Academic

16. Education on red-flag symptoms.
    Teach families to watch for fever, mouth sores, skin redness, cough, painful urination, or behavior changes. Early action saves time. Infectious Diseases Society of America

17. Safe play and activity.
    Regular play and exercise are healthy. Avoid high-risk injury settings when counts are very low to reduce skin breaks and infections. MedlinePlus

18. Antibiotic stewardship at home.
    Do not start “leftover” antibiotics without medical advice. Proper use prevents resistance and ensures right therapy when truly needed. OUP Academic

19. Care coordination (hematology + infectious disease + dentistry).
    A shared plan aligns prevention, rapid treatment, and monitoring for complications. Team care improves outcomes. ASH Publications

20. Genetic counseling and family testing.
    SCN4 is autosomal recessive. Counseling explains risks for future pregnancies and helps relatives access testing. NCBI

---

Drug treatments

1. Filgrastim (NEUPOGEN® and biosimilars) — G-CSF.
   What it does: Raises neutrophil counts and reduces infections; cornerstone therapy in severe congenital neutropenia. Dose/time (label examples): Common starting 5 mcg/kg/day SC; dose titrated to keep ANC in a safe range; daily dosing is typical for chronic neutropenia (specialist adjusts). Mechanism: Recombinant G-CSF stimulates neutrophil production and release. Side effects: Bone pain, injection-site pain; rare splenic rupture, glomerulonephritis, and sickle crisis; allergic reactions possible. Purpose: Prevent life-threatening infections by correcting neutropenia. FDA Access Data+3FDA Access Data+3FDA Access Data+3

2. Pegfilgrastim (NEULASTA® and pegfilgrastim products) — long-acting G-CSF.
   What it does: Longer-acting form; used widely in chemo settings and sometimes in congenital neutropenia under specialist care. Dose/time (label examples): Fixed 6 mg SC per cycle in oncology; pediatric mg/kg regimens studied; for congenital neutropenia, schedules are individualized by experts. Mechanism: Pegylation extends G-CSF activity to sustain neutrophil support. Side effects: Bone pain; rare splenic rupture and serious allergy. Purpose: Fewer injections with sustained neutrophil support. FDA Access Data+2FDA Access Data+2

3. Tbo-filgrastim (GRANIX®) — G-CSF.
   Another recombinant G-CSF used in oncology; some centers consider it when access or tolerance issues arise; dosing and risks are similar in principle to filgrastim (specialist decision). ASCO Publications

4. Filgrastim-sndz (ZARXIO®) — biosimilar G-CSF.
   Biosimilar filgrastim with comparable mechanism and safety warnings; used when appropriate based on access and clinician choice. FDA Access Data

5. Filgrastim-aafi (NIVESTYM®) — biosimilar G-CSF.
   Similar role and precautions to originator filgrastim; choice depends on local formularies and clinical judgment. FDA Access Data

6. Pegfilgrastim-fpgk (biosimilar) — long-acting G-CSF.
   FDA-approved pegfilgrastim product; same overall mechanism and key warnings as reference pegfilgrastim. FDA Access Data

7. Empiric broad-spectrum IV antibiotics for febrile neutropenia (e.g., cefepime, piperacillin-tazobactam, or meropenem).
   Purpose: Immediate treatment of fever in neutropenia to cover gram-negative and other serious bacteria. Mechanism: Rapid bactericidal activity against likely pathogens. Side effects: Drug-specific (e.g., GI upset, rash, rare C. difficile). Used per guideline pathways. OUP Academic+1

8. Targeted anti-staphylococcal therapy when needed (e.g., vancomycin, linezolid) per cultures and severity.
   Purpose: Add coverage when resistant gram-positive infection is suspected (e.g., catheter infection, skin infection, unstable patient). Mechanism: Blocks bacterial cell wall or protein synthesis. Risks: Drug-specific myelosuppression, kidney, or platelet effects; monitor closely. OUP Academic

9. Antifungal therapy for persistent fever on antibiotics (e.g., echinocandin, voriconazole) when indicated.
   Purpose: Treat or prevent invasive fungal disease in high-risk, prolonged neutropenia with persistent fever. Mechanism: Inhibits fungal cell wall or ergosterol pathway. Risks: Liver tests, drug interactions. OUP Academic

10. Antiviral therapy when specific viruses are proven or strongly suspected.
    Used based on testing and clinical picture; reduces viral complications in vulnerable patients. OUP Academic

11. Prophylactic antibiotics in select high-risk cases (specialist-directed).
    Some centers use prophylaxis (e.g., trimethoprim-sulfamethoxazole) to reduce bacterial infections in patients with very low ANC and recurrent infections. Decisions are individualized to balance benefit and resistance. OUP Academic

12. Topical oral agents for mucositis and ulcers (e.g., chlorhexidine per dental guidance).
    Purpose: Lower mouth bacterial load and pain. Mechanism: Antiseptic effect; supports oral hygiene. Risks: Taste change, staining. NCBI

13. Topical antiseptics for skin breaks (e.g., povidone-iodine as directed).
    Purpose: Reduce local bacteria at minor wounds. Mechanism: Broad antimicrobial activity. Risks: Local irritation; follow clinician advice. OUP Academic

14. Growth factor dose optimization (titration strategy).
    Clinicians raise or lower G-CSF doses to keep counts safe while avoiding excess side effects. Regular CBC monitoring is essential. FDA Access Data

15. Switching between daily G-CSF and long-acting options when appropriate.
    Helps adherence, comfort, and count stability; chosen by specialists based on response and safety. FDA Access Data

16. Management of G-CSF adverse effects.
    Bone pain may improve with dose timing or simple analgesics; rare splenic pain needs urgent evaluation. Kidney signs (protein in urine) or allergic symptoms need prompt review and sometimes dose changes. FDA Access Data+1

17. Monitoring for clonal evolution (e.g., CSF3R mutations) and leukemia/MDS risk.
    Long-term SCN carries a risk of MDS/AML; registry data guide timing of transplant decisions for non-responders or those showing worrisome changes. PMC+1

18. Pre-emptive antifungal or antiviral prophylaxis in prolonged severe neutropenia (case-by-case).
    Chosen for those with repeated or persistent risk patterns; follows institutional pathways. OUP Academic

19. Immunization of household contacts (cocooning).
    Vaccinating close contacts (flu, pertussis, etc.) reduces exposure to the patient. CDC

20. Hematopoietic stem-cell transplant (HSCT) medications around the procedure (conditioning, immunosuppressants).
    For patients who fail G-CSF or develop MDS/AML, HSCT can cure marrow failure; transplant drugs are part of that pathway and are managed by transplant centers. PMC+1

Important note: The only drugs with FDA labels specifically cited here are G-CSF products (filgrastim/pegfilgrastim and biosimilars). Dosing for congenital neutropenia is individualized by specialists; always use the current FDA label and center protocols. FDA Access Data+4FDA Access Data+4FDA Access Data+4

---

Dietary molecular supplements

1. Vitamin C.
   Supports collagen and skin healing and may help neutrophil function. It does not replace G-CSF or antibiotics but supports barrier repair. Typical dietary intake or clinician-guided supplement can be used. MedlinePlus

2. Vitamin D.
   Low vitamin D is linked with more infections; repletion supports innate immunity. Dose is based on blood level and clinician guidance. MedlinePlus

3. Zinc.
   Zinc deficiency impairs immune barriers and wound healing. Short, supervised courses correct deficiency and may aid skin/mucosa health. MedlinePlus

4. Iron (only if iron-deficient).
   Iron helps red blood cells and enzymes, but excess can fuel bacteria. Use only after testing shows deficiency. MedlinePlus

5. Folate & B12 (if low).
   These vitamins support DNA synthesis. Correcting deficiencies helps marrow function overall, though they do not cure SCN4. MedlinePlus

6. Protein-rich nutrition (amino acids).
   Adequate protein supports tissue repair and immune proteins. Balanced diet or dietitian-guided shakes may help catch-up growth. MedlinePlus

7. Omega-3 fatty acids.
   May modulate inflammation and support mucosal health. Use food sources (fish) or supervised supplements. MedlinePlus

8. Probiotics (use with caution; specialist advice).
   Some centers avoid in profound neutropenia due to rare bacteremia risks. If considered, choose well-studied strains and stop if fever occurs. OUP Academic

9. Selenium (if low).
   Antioxidant roles may support immune balance; correct only if deficiency is proven to avoid toxicity. MedlinePlus

10. Multivitamin (age-appropriate).
    A simple once-daily multivitamin helps cover minor gaps but is not a treatment for neutropenia. MedlinePlus

---

Immunity-booster / regenerative / stem-cell” drugs

1. Filgrastim (G-CSF).
   True, proven “neutrophil-regenerative” therapy for SCN: it drives marrow to make neutrophils and release them. Dosing is individualized and adjusted by ANC and side effects (bone pain, rare spleen or kidney issues). It is the first-line medicine that changed survival in SCN. FDA Access Data+1

2. Pegfilgrastim (long-acting G-CSF).
   Same mechanism as filgrastim with a longer half-life due to pegylation. Some centers use it for convenience; safety warnings mirror filgrastim. Decisions are case-by-case in congenital neutropenia. FDA Access Data

3. GM-CSF (sargramostim) — selected cases.
   Stimulates monocytes/macrophages and some granulocytes; sometimes tried if G-CSF response is suboptimal. It is not standard for SCN4 and needs specialist oversight. OUP Academic

4. HSCT conditioning drugs (e.g., busulfan-based regimens).
   Not “immunity boosters,” but part of curative transplant. They prepare marrow to accept donor stem cells when G-CSF fails or MDS/AML appears. Frontiers

5. Immunoglobulin (IVIG) in selected scenarios.
   IVIG does not fix neutropenia but may be used for specific antibody-related issues or recurrent infections under specialist care. OUP Academic

6. Future gene therapy (investigational).
   Experimental gene correction is being studied for inherited neutropenias, but it is not standard of care yet for G6PC3-SCN4. HSCT remains the only proven cure. PMC

---

Surgeries / procedures

1. Central venous catheter placement (when necessary).
   Allows safe delivery of IV antibiotics and transfusions during severe infections. Done only when benefits exceed infection risks, with strict line-care to prevent bloodstream infection. OUP Academic

2. Incision and drainage of abscesses.
   When pus collects, opening and draining it reduces bacterial load and speeds healing, paired with antibiotics. OUP Academic

3. Dental procedures for infection control.
   Extraction or periodontal care removes bacterial sources that fuel recurrent infections, performed with antibiotic plans when counts are low. NCBI

4. Hematopoietic stem-cell transplantation (HSCT).
   Curative for marrow failure in SCN when G-CSF fails, adverse clonal changes arise, or MDS/AML develops. Timing is key: outcomes are better before advanced MDS/AML. PMC+2ASH Publications+2

5. Line removal for catheter infections.
   If a central line is the infection source and cannot be sterilized, removing it is part of cure. OUP Academic

---

Preventions

1. Up-to-date vaccines for patient and household (flu yearly; pneumococcal per guidance). CDC

2. Prompt care for any fever. Infectious Diseases Society of America

3. Hand hygiene every day, every caregiver. World Health Organization

4. Dental hygiene and regular dentist visits. NCBI

5. Food and water safety at home. OUP Academic

6. Skin care and fast cleaning of cuts. MedlinePlus

7. Avoid unnecessary invasive devices. OUP Academic

8. School/day-care infection control and sick-day rules. World Health Organization

9. No smoking exposure in the home/car. OUP Academic

10. Regular specialist follow-up with CBCs and growth checks. ASH Publications

---

When to see doctors (or go to emergency)

Go now for any fever, chills, fast breathing, severe sore throat, mouth ulcers with drooling, painful urination, new belly pain (especially left upper side which could signal spleen issues on G-CSF), new rash with fever, or unusual sleepiness. Go quickly if there is shoulder/left-upper belly pain on G-CSF (possible splenic problem). Contact your team for poor feeding, weight loss, new bleeding, or if medicines cause new swelling, hives, or breathing trouble. Infectious Diseases Society of America+1

---

What to eat & what to avoid

1. Eat well-cooked meats, eggs, and fish; avoid undercooked/raw items (e.g., runny eggs, sushi for young children). OUP Academic

2. Eat clean, well-washed fruits/vegetables; avoid unwashed produce. OUP Academic

3. Drink safe, treated water; avoid untreated sources. OUP Academic

4. Use pasteurized milk and cheeses; avoid unpasteurized dairy. OUP Academic

5. Aim for balanced meals with protein, whole grains, fruits, and vegetables; avoid extreme, restrictive diets. MedlinePlus

6. Consider dietitian support if appetite or growth is poor. MedlinePlus

7. Handle kitchen tools safely; separate raw and cooked foods. OUP Academic

8. Limit sugary drinks and ultra-processed snacks; support general health. MedlinePlus

9. Ask your team before probiotics or herbal products. OUP Academic

10. Keep good mouth hydration (water) to help oral comfort and healing. NCBI

---

FAQs

1) Is SCN4 the same as “Kostmann syndrome”?
“Kostmann” originally described severe congenital neutropenia; many genes can cause it. SCN4 specifically refers to G6PC3 mutations. ASH Publications

2) Can SCN4 improve with age?
Neutropenia is usually lifelong. Many patients need ongoing G-CSF, but individual responses vary. ASH Publications

3) Is G-CSF safe for long-term use?
It is the standard, life-saving therapy. Long-term registry data show reduced death from sepsis but a background risk of MDS/AML in SCN that needs monitoring. Care teams balance benefit and risk and watch for warning signs. PMC

4) Does G-CSF cause leukemia?
SCN itself carries leukemia/MDS risk. Studies from the SCN registry show the risk over time in patients on G-CSF; doctors monitor for clonal changes and consider HSCT if risk rises or response fails. PubMed

5) When is HSCT considered?
If G-CSF does not keep ANC safe, infections remain severe, or if clonal evolution/MDS/AML appears. Earlier HSCT (before advanced MDS/AML) leads to better outcomes. PMC+1

6) Are live vaccines allowed?
Many experts allow live viral vaccines in isolated neutropenia after specialist review, but US CDC cautions in altered immunocompetence. Plans are individualized. Inactivated vaccines should be up to date. PMC+1

7) What ANC number is “severe”?
Severe neutropenia is ANC <500/µL. In SCN, counts are often far below this without G-CSF. MedlinePlus

8) Why do mouth ulcers happen so often?
Low neutrophils let mouth bacteria trigger ulcers and gum swelling. Good dental care and count support help. NCBI

9) Do all patients have other organ problems?
Not all. Some with G6PC3 variants have extra features (e.g., heart or urogenital differences), while others mainly have neutropenia. PMC

10) Can diet fix neutropenia?
No. Diet supports healing, but G-CSF and infection control are the main therapies. ASH Publications

11) Are biosimilar G-CSFs OK?
Biosimilars work via the same mechanism and carry similar warnings. Choice depends on your clinician and access. FDA Access Data

12) What side effects need urgent care on G-CSF?
Severe left-upper belly/shoulder pain (possible spleen issue), breathing trouble, hives, or dark/foamy urine need prompt evaluation. FDA Access Data+1

13) Why do we do regular blood tests?
To keep ANC in a safe range and check for signs of clonal change or drug effects. FDA Access Data

14) Is gene therapy available?
Not yet as standard for SCN4; research continues. HSCT is the proven curative option when needed. PMC

15) Can children with SCN4 live active lives?
With strong prevention, fast fever care, proper G-CSF dosing, and dental and vaccine plans, many children attend school and play safely. ASH Publications

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 13, 2025.